Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Marizyme
AddedFeb 19, 2024
UpdatedJun 18, 2026
Marizyme

Marizyme

Public

Marizyme, a tech company focused on developing therapies for acute care using ProteomeX, a novel system of proteolytic enzymes.

HQ
Jupiter, FL, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Marizyme, founded as a multi-technology biomedical company, is dedicated to the accelerated development and commercialization of medical technologies aimed at improving patient health outcomes. The company's core mission is to address urgent needs in acute care by leveraging its proprietary system of proteolytic enzymes, ProteomeX. Marizyme focuses on developing therapies that can reduce high mortality rates and healthcare costs associated with acute conditions. Their market focus includes hospitals and healthcare providers seeking innovative solutions for critical care.

Notable figures affiliated with Marizyme include its team of biomedical experts and strategic investors who support its mission of transforming acute care. Key achievements include the acquisition and development of ProteomeX technology, positioning Marizyme as a leader in enzyme-based therapeutic solutions. The company has made significant strides in advancing its product candidates, contributing to improved patient outcomes and setting new standards in the acute care sector.

Marizyme - Quick Facts

When was Marizyme founded?

Marizyme was founded in 2018.

Where is Marizyme's headquarters located?

Marizyme's headquarters is located in Jupiter, FL, US.

When was Marizyme's last funding round?

Marizyme's most recent funding round was for $5.6M (USD) in August 2020.

How much has Marizyme raised to-date?

As of Aug 4, 2020, Marizyme has raised a total of $5.6M (USD).

How many employees does Marizyme have?

Marizyme has 14 employees as of Feb 6, 2024.

Marizyme - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
  • Government
Main Product
  • Medical Therapies
Tags
  • Biotech
  • Healthtech
NAICS
  • 337000Furniture and Related Product Manufacturing
  • 337100Household and Institutional Furniture and Kitchen Cabinet Manufacturing
  • 337120Household and Institutional Furniture Manufacturing
  • 337127Institutional Furniture Manufacturing
  • 330000Manufacturing
SIC
  • 3840Surgical, Medical, And Dental Instruments And Supplies
  • 3841Surgical And Medical Instruments And Apparatus
ISIC
  • 2520Manufacture of weapons and ammunition
  • 2815Manufacture of ovens, furnaces and furnace burners
  • 3250Manufacture of medical and dental instruments and supplies
Show 37 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 332000Fabricated Metal Product Manufacturing
  • 332900Other Fabricated Metal Product Manufacturing
  • 332990All Other Fabricated Metal Product Manufacturing
  • 332994Small Arms, Ordnance, and Ordnance Accessories Manufacturing
  • 333200Industrial Machinery Manufacturing
  • 333240Industrial Machinery Manufacturing
  • 333248All Other Industrial Machinery Manufacturing
  • 333400Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333410Ventilation, Heating, Air-Conditioning, and Commercial Refrigeration Equipment Manufacturing
  • 333415Air-Conditioning and Warm Air Heating Equipment and Commercial and Industrial Refrigeration Equipment Manufacturing
  • 333900Other General Purpose Machinery Manufacturing
  • 333990All Other General Purpose Machinery Manufacturing
  • 333994Industrial Process Furnace and Oven Manufacturing
  • 333998All Other Miscellaneous General Purpose Machinery Manufacturing
  • 339100Medical Equipment and Supplies Manufacturing
  • 339110Medical Equipment and Supplies Manufacturing
  • 339112Surgical and Medical Instrument Manufacturing
  • 339113Surgical Appliance and Supplies Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 333000Machinery Manufacturing
  • 339000Miscellaneous Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5020Furniture And Homefurnishings
  • 2800Chemicals And Allied Products
  • 4000Railroad Transportation
  • 5000Wholesale Trade-durable Goods
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products